Home>Topics>Stocks>Valeant Pharmaceuticals International

Valeant Pharmaceuticals International VRX

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. CANADA STOCKS-TSX falls as Scotiabank, Valeant lead declines

      Headlines

      Tue, 3 Mar 2015

      exchange fell shortly after the open on Tuesday in a broad decline led in part by the Bank of Nova Scotia, which reported a lower-than-expected quarterly profit, and a sell off in Valeant Pharmaceuticals International Inc shares.

    2. CANADA STOCKS-TSX advances as Valeant climbs, offsets weaker oil shares

      Headlines

      Mon, 2 Mar 2015

      TORONTO, March 2 (Reuters) - Canada's main stock index rose on Monday as a jump in Valeant Pharmaceuticals International Inc helped offset weakness in the energy sector after the price of Brent crude oil dropped.

    3. Compelling Financial Benefit in Valeant's Latest Buy

      Headlines

      Fri, 27 Feb 2015

      The $14.5 billion acquisition of Salix Pharmaceuticals SLXP brings Valeant Pharmaceuticals VRX into an entirely new therapeutic area, but the deal is very compelling financially. Management expects the deal to increase 2016

    4. Canada's Valeant to buy Salix in $10.1 billion deal

      Headlines

      Mon, 23 Feb 2015

      NEW YORK (Reuters) - Canada's Valeant Pharmaceuticals International Inc agreed to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd in an all-cash deal valued at about $10.1 billion, the two companies said on Sunday.

    5. UPDATE 3-Valeant eyes smaller deals to build on Salix, Dendreon purchases

      Headlines

      Mon, 23 Feb 2015

      Feb 23 (Reuters) - Valeant Pharmaceuticals International Inc plans to strike smaller deals to build on its acquisitions of Salix Pharmaceuticals Ltd and assets of Dendreon Corp, its chief executive...

    6. UPDATE 3-Canada's Valeant to acquire Salix in $10.1 billion deal

      Headlines

      Sun, 22 Feb 2015

      NEW YORK, Feb 22 (Reuters) - Canada's Valeant Pharmaceuticals International Inc agreed to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd in an all-cash deal valued at about $10.1...

    7. RPT-UPDATE 2-Canada's Valeant to acquire Salix in $10.1 billion deal

      Headlines

      Sun, 22 Feb 2015

      NEW YORK, Feb 22 (Reuters) - Canada's Valeant Pharmaceuticals International Inc agreed to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd in an all-cash deal valued at about $10.1 billion, the two companies said on Sunday.

    8. Canada's Valeant to acquire Salix in $10.1 billion deal

      Headlines

      Sun, 22 Feb 2015

      NEW YORK (Reuters) - Canada's Valeant Pharmaceuticals International Inc agreed to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd in an all-cash deal valued at about $10.1 billion, the two companies said on Sunday.

    9. UPDATE 2-Canada's Valeant to acquire Salix in $10.1 billion deal

      Headlines

      Sun, 22 Feb 2015

      NEW YORK, Feb 22 (Reuters) - Canada's Valeant Pharmaceuticals International Inc agreed to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd in an all-cash deal valued at about $10.1...

    10. Valeant to acquire Salix in $14.5 bln deal

      Headlines

      Sun, 22 Feb 2015

      NEW YORK, Feb 22 (Reuters) - Valeant Pharmaceuticals International Inc. agreed to acquire Salix Pharmaceuticals Ltd. for $158.00 per share, or a total enterprise value of $14.5 billion, the two companies said on Sunday.

    « Prev12345Next »
    Content Partners